
Makes even hard topics easy to grasp.
Always supportive and inspiring to all.
Makes even the toughest topics accessible.
Inspires a passion for knowledge and growth.
Great Professor!
Dr Bryony Ross is a Conjoint Associate Professor in the School of Medicine and Public Health, College of Health, Medicine and Wellbeing, at the University of Newcastle, Australia. She holds qualifications of B.Biomed.Sc, MBBS, FRACP, and FRCPA. As a haematologist affiliated with John Hunter Hospital, she serves as hematopathologist at the John Hunter laboratory of NSW Health Pathology, clinical physician at John Hunter Children’s Hospital, and Transfusion Clinical Stream Lead at NSW Health Pathology. Ross specializes in haematology and oncology, with clinical and research experience in adult and paediatric haematopathology and transfusion medicine. Her interests include patient blood management and blood transfusion policy. She chairs the ANZSBT Clinical Transfusion Committee, NSW Blood Management Clinical Advisory Committee with the Clinical Excellence Commission, and NSW Blood and Blood Products Wastage Reduction Working Party. She has co-authored paediatric and neonatal chapters in Clinical Examination by Talley and O’Connor.
Her research has produced numerous publications advancing transfusion practices and haematology. Key works include 'Serological screening for cytomegalovirus in a leucodepleted blood supply: A systematic review' (2026), 'Iron optimisation in pregnancy: a Haematology in Obstetric and Women's Health Collaborative consensus statement' (2025), 'The incidence of donor white blood cell survival (transfusion-associated microchimerism) in Australian pediatric patients' (2024), 'Iron deficiency in women: clearing the rust of silence' (The Lancet Haematology, 2022), 'Every one counts: A retrospective cohort study examining the safety of extending pre-transfusion compatibility testing from 72 hours to 7 days in hematology patients receiving red blood cell transfusions' (2023), 'Transfusion-associated circulatory overload in ambulatory patients' (2019), 'Zeroing in on red blood cell unit expiry' (2017), and 'Development of novel PP2A activators for use in the treatment of acute myeloid leukaemia' (2016). Additional publications address viscoelastic haemostatic assays in paediatric acute traumatic coagulopathy, adherence to antenatal haemoglobinopathy screening, and embedding best transfusion practices in neonatal intensive care. Ross collaborates with researchers such as Anoop K. Enjeti, Matt Dun, and Nikki Verrills on projects including an NHMRC Project Grant. Her contributions enhance transfusion safety, reduce wastage, and improve outcomes in obstetric, neonatal, and paediatric haematology.